Serious adverse events were balanced across groups
Further weight loss (1015 kg) extends benefits to conditions like sleep apnoea, acid reflux, and osteoarthritis while exceeding 15 kg is strongly linked to type 2 diabetes remission and improved cardiovascular function.[17] Approved anti-obesity medications, like orlistat, liraglutide, naltrexone-bupropion, and phentermine-topiramate, offer modest weight loss (35 kg).[17] Liraglutides 3 mg/day injection leads to an 8% reduction after one year.[18] Semaglutide achieves up to 16% weight loss with a weekly 2.4 mg subcutaneous injection over a year.[19,20,21] Tirzepatide, a dual GIP and GLP1RA, exhibits an 11.9% to 12.4% weight reduction at 10 mg and 15 mg doses per week over 618 months.[22,23] In this context, our meta-analysis highlights the impressive weight loss achieved with cagrilintide-based therapies, particularly with cagrisema 2.4/2.4 mg, which was noted to be superior to semaglutide 2.4 mg in terms of both percentage and absolute weight loss over a 6-month clinical use period, albeit at the expense of increased gastrointestinal side effects
(the parent company) is accredited by the Better Business Bureau (BBB) and has an A+ rating
doi:10.1136/vr.152.15.457
Skin Whitening: Glutathione protects from the synthesis of melanin, creating a more radiant, clear complexion
